Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Morton

Showing results (941-950 of 1,110) with videos related to

Pageof 111
Sort By:
Heart, Lung & Circulation|June 6, 2021
Translation and Impact of Funded Australian Cardiovascular Research: A Review With PerspectiveAlexis J Hure, Shanthi Ramanathan, Simon Deeming, et al.
Annals of Surgery|December 29, 2011
Assessment of prognostic circulating tumor cells in a phase III trial of adjuvant immunotherapy after complete resection of stage IV melanomaSojun Hoshimoto, Mark B Faries, Donald L Morton, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 25, 1998
Phase I study of a five-day dose schedule of 4-Ipomeanol in patients with non-small cell lung cancerV K Kasturi, M P Dearing, S C Piscitelli, et al.
Pediatric Blood & Cancer|July 31, 2010
Initial testing (stage 1) of the multi-targeted kinase inhibitor sorafenib by the pediatric preclinical testing programStephen T Keir, John M Maris, Richard Lock, et al.
Pediatric Blood & Cancer|February 8, 2011
Initial testing (stage 1) of the IGF-1 receptor inhibitor BMS-754807 by the pediatric preclinical testing programE Anders Kolb, Richard Gorlick, Richard Lock, et al.
Pediatric Blood & Cancer|May 7, 2009
Initial testing (stage 1) of vorinostat (SAHA) by the pediatric preclinical testing programNino Keshelava, Peter J Houghton, Christopher L Morton, et al.
Pediatric Blood & Cancer|May 7, 2009
Initial testing of aplidin by the pediatric pre-clinical testing programChristopher L Morton, Peter J Houghton, Richard Gorlick, et al.
The British Journal of Dermatology|February 2, 2012
Aberrant hypermethylation in primary tumours and sentinel lymph node metastases in paediatric patients with cutaneous melanomaK T Huynh, Y Takei, C Kuo, et al.
Annals of Surgical Oncology|February 10, 2022
The Impact of Surveillance Imaging Frequency on the Detection of Distant Disease for Patients with Resected Stage III MelanomaMbathio Dieng, Sarah J Lord, Robin M Turner, et al.
Pediatric Blood & Cancer|January 29, 2010
Initial testing of the aurora kinase A inhibitor MLN8237 by the Pediatric Preclinical Testing Program (PPTP)John M Maris, Christopher L Morton, Richard Gorlick, et al.
Pageof 111

Showing results (941-950 of 1,110) with videos related to

Sort By:
Pageof 111
Heart, Lung & Circulation|June 6, 2021
Translation and Impact of Funded Australian Cardiovascular Research: A Review With PerspectiveAlexis J Hure, Shanthi Ramanathan, Simon Deeming, et al.
Annals of Surgery|December 29, 2011
Assessment of prognostic circulating tumor cells in a phase III trial of adjuvant immunotherapy after complete resection of stage IV melanomaSojun Hoshimoto, Mark B Faries, Donald L Morton, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 25, 1998
Phase I study of a five-day dose schedule of 4-Ipomeanol in patients with non-small cell lung cancerV K Kasturi, M P Dearing, S C Piscitelli, et al.
Pediatric Blood & Cancer|July 31, 2010
Initial testing (stage 1) of the multi-targeted kinase inhibitor sorafenib by the pediatric preclinical testing programStephen T Keir, John M Maris, Richard Lock, et al.
Pediatric Blood & Cancer|February 8, 2011
Initial testing (stage 1) of the IGF-1 receptor inhibitor BMS-754807 by the pediatric preclinical testing programE Anders Kolb, Richard Gorlick, Richard Lock, et al.
Pediatric Blood & Cancer|May 7, 2009
Initial testing (stage 1) of vorinostat (SAHA) by the pediatric preclinical testing programNino Keshelava, Peter J Houghton, Christopher L Morton, et al.
Pediatric Blood & Cancer|May 7, 2009
Initial testing of aplidin by the pediatric pre-clinical testing programChristopher L Morton, Peter J Houghton, Richard Gorlick, et al.
The British Journal of Dermatology|February 2, 2012
Aberrant hypermethylation in primary tumours and sentinel lymph node metastases in paediatric patients with cutaneous melanomaK T Huynh, Y Takei, C Kuo, et al.
Annals of Surgical Oncology|February 10, 2022
The Impact of Surveillance Imaging Frequency on the Detection of Distant Disease for Patients with Resected Stage III MelanomaMbathio Dieng, Sarah J Lord, Robin M Turner, et al.
Pediatric Blood & Cancer|January 29, 2010
Initial testing of the aurora kinase A inhibitor MLN8237 by the Pediatric Preclinical Testing Program (PPTP)John M Maris, Christopher L Morton, Richard Gorlick, et al.
Pageof 111